Contact us
Log in
20 € - 150 € Seats available
Category Price
PHD students and residents 20 €
ILCA members 100 €
non-ILCA members 150 €
Coming session
Starts Dec. 11, 2020 8:30 am
Ends Dec. 12, 2020 12:30 pm
Timezone : Europe/Paris Convert training time to my timezone
More details ?
Contact us
+33 5 56 70 32 05

Innovations in primary liver cancer

Online
Webinar
Oncology
2-day course / 14:30 effective hours
300 attendees per session
English

Course details

The next ILCA School of Liver Cancer will take place online!


ILCA is very pleased to announce that the next edition of the ILCA School of Liver Cancer will take place online, it will be hosted by Arte Studio on 11−12 December 2020.

Who is this course for?

Liver cancer related specialties

Technical requirements

Correct connection to a Wi-Fi network is recommended for quality sound and image.

The Webinar is also accessible by Smartphone, but a computer is however recommended for more comfort. If you are connecting from a smartphone or tablet, you will need to download the Zoom app.

Technical prerequisites:

Laptop or smartphone with stable internet connection. Helmet recommended but not required.

Supported browsers:

Windows: IE7 +, Firefox, Chrome, Safari5 +

Mac: Safari5 +, Firefox, Chrome

Linux: Firefox, Chrome

For more details, see the following link: https://bit.ly/2woSTeH

Test your hardware: https://zoom.us/test

Test your connection: 5-10 Mbps download recommended speed. Check your connection at https://www.speedtest.net/

Price categories

Category
Price
ILCA members
100 €
non-ILCA members
150 €
PHD students and residents
20 €

Agenda

Friday 11th December 2020


08h25-08h30: opening remarks

Jean-Charles Nault (Avicenne Hospital, Bobigny, APHP, Cordeliers research center, Paris), Eric Vibert (Paul Brousse hospital, Villejuif, APHP)


The hepatocellular carcinoma session

Risk factors, screening and diagnosis of HCC: What is new ?

08h30-08h45: Perspective on epidemiology and HCC screening in the era of NASH -Nathalie Ganne-Carrie (Avicenne Hospital, Bobigny, APHP, Cordeliers research center, Paris)

08h45-09h00: Understanding the physiopathology of NASH related HCC - Mathias Heikenwalder (Heidelberg, DKFZ)

09h00-09h15: Update on the Imaging Diagnosis of HCC - Alain Luciani (Mondor Hospital, Créteil, APHP)

09h15-09h30: The future of HCC pathology - Julien Calderaro (Mondor Hospital, Créteil, APHP)

09h30-10H00: Blast session on hot topic: controversies in HCC screening and diagnosis

-      Impact of antiviral treatment on tumor occurrence and recurrence - Pierre Nahon (Avicenne Hospital, Bobigny, APHP, Cordeliers research center, Paris)

-      Why and how to assess non-tumor liver in HCC patients ? - François Durand (Beaujon Hospital, Clichy, APHP)

           (blast session: 2 X 10 mn presentation + 10 mn discussion)


10h00-10h30 Virtual Coffee break


Early HCC: can we go beyong guidelines ?

10h30-10h45: Preclinical models of HCC and prediction of therapeutic response - Sandra Rebouissou (Cordeliers research center, Paris)

10h45-11h00: Why and how to expend criteria for surgery? - Eric Vibert (Paul Brousse hospital, Villejuif, APHP)

11h00-11h15: Current knowledge and innovation in percutaneous treatment of HCC - Olivier Seror (Avicenne Hospital, Bobigny, APHP, Cordeliers research center, Paris)

11h15-11h30: Blast session on hot topic: can we improve treatment of early HCC ?

- The place of mini invasive surgery : short term advantages and bridge to liver transplantation - Olivier Scatton (Pitié-Salpétrière Hospital, Paris, APHP)

- Can we expend criteria of liver transplantation beyond composite criteria ? - Christophe Duvoux (Mondor Hospital, Créteil, APHP)

(blast session: 2 X 10 mn presentation + 10 mn discussion)


11h30-12h00: Break


Evidence and doubt about management of Intermediate HCC

12h00-12h15: Current knowledge of endovascular treatment of HCC (except SIRT) - Thierry De Baere (Institut Gustave Roussy, Villejuif)

12h15-12H30: Assessment of radiological response: conventional and functional imaging of HCC - Maxime Ronot (Beaujon Hospital, Clichy, APHP)

12h30-13h00: Blast session on hot topics: role of SIRT in 2020

-      SIRT Pro - Boris Guiu (CHU Montpellier)

-      SIRT Against - Tim Meyer (Royal Free Hospital, London)

           (blast session: 2 X 10 mn presentation followed by 10 mn discussion)


13h00-14h00: Lunch


14H00-14H15: State of the art: Jessica Zucman-Rossi (Cordeliers research center, Paris) Genomic of hepatocellular carcinoma


Present and future of advanced HCC: immunotherapy

14h15-14h30: liver immunology and HCC for the dummies - Amaia Lujambio (USA)

14h30-14h45: immunotherapy of HCC hope and hype - Thomas Decaens (CHU Grenoble)

14h45-15h15: Blast session on hot topics: new questions rise with immunotherapy

-      Can we identify predictor of response to immunotherapy ? The immuno-oncologist point of view - Stéphane Champiat (Institut Gustave Roussy, Villejuif)

-      Management of adverse events of immunotherapy - Mohamed Bouattour (Beaujon Hospital, Clichy, APHP)

          (blast session: 2 X 10 mn presentation followed by 10 mn discussion)


15h15-15h30: break


Present and future of advanced HCC: targeted therapy

15h30-15h45: Non-invasive biomarkers in HCC - Augusto Villanueva (Mount Sinai Hospital, New-York)

15h45-16h00: Current and future role of targeted therapy in the management of advanced HCC - Peter Galle (University Medical Center, Mainz)

16h00-16h30: Blast session on hot topics: improving results of targeted therapy

-      Potential role of combination therapy in HCC - Olivier Rosmorduc (Paul Brousse hospital, Villejuif, APHP)

-      Reason of failure and success of phase 3 randomized controlled trial - Sandrine Faivre (Saint Louis Hospital, Paris, APHP)

          (blast session: 2 X 10 mn presentation followed by 10 mn discussion)


16h30-16h45: State of the Art. Classification and treatment of HCC: a historical perspective - Prof. Jordi Bruix


Saturday 12th December 2020


Clinical case: round of discussion


Early HCC

09H00-09H30: A multidisciplinary approach of a case (Panel: Daniel Cherqui, Valérie Paradis, Olivier Seror, Jordi Bruix)

Presentation of case report: A small HCC with aggressive features - Manon Allaire (Pitié-Salpétrière, Paris, APHP)


Cholangiocarcinoma

09h30-10h00: A multidisciplinary approach of a case (Panel: Eric Vibert, Thierry De Baere, Sandrine Faivre, Olivier Rosmorduc)

Presentation of case report: cholangiocarcinoma - Marie Lequoy (Saint Antoine hospital, Paris, APHP)


Intermediate HCC

10H00-10H30: A multidisciplinary approach of a case (Panel: René Adam, Valérie Vilgrain, Christophe Duvoux, Jean Charles Nault)

Presentation of case report: An intermediate HCC - Giuliana Amaddeo (Mondor Hospital, Créteil, APHP)


Break: 10h30-11h00


The cholangiocarcinoma session

11h00-11h15: Pathogenesis of cholangiocarcinoma and cell of origin - Lars Zender (University of Tubingen)

11h15-11h30: Primary liver cancers and mixed tumors: a continuum ? The molecular biologist/pathologist point of view - Valérie Paradis (Beaujon Hospital, Clichy, APHP)

11h30-11h45: Systemic treatment of cholangiocarcinoma: to a personalized medicine - Julien Edeline (Centre Eugène Marquis, Rennes)

11h45-12h00: Blast session on hot topics: what is the best option for curative treatment of intrahepatic and extrahepatic cholangiocarcinoma ?

-      Resection - Olivier Soubrane (Beaujon Hospital, Clichy, APHP)

-      Transplantation - Emmanuel Boleslaswki (Hôpital Huriez, CHU Lille)

          (blast session: 2 X 10 mn presentation followed by 10 mn discussion)

12h00-12h05: Closing remarks

Jean-Charles Nault (Avicenne Hospital, Bobigny, APHP, Cordeliers research center, Paris), Eric Vibert (Paul Brousse hospital, Villejuif, APHP)


12h05: End of the day